Mark Goldstone

Ansella Therapeutics is a specialty pharmaceutical company that focuses on the often overlooked details of well-understood biological systems and leverages novel materials science to create new treatment options for women’s health. Our patented, bio-inspired platform technology gives rise to a pipeline of over-the-counter (OTC) and prescription products that target improving vaginal health at all stages in life. Our flagship personal lubricant product is a first-in-class, biomimetic cream that unlocks the potential of cholesterol and fatty acids to maintain favorable cellular properties in the vaginal epithelium. Ultimately, this product is designed to mimic cervical and vaginal secretions and interface well with the dynamic vaginal mucosa.

BayBridgeDigital is a game changing new company that drives digital transformation to create new growth and business value faster. BayBridgeDigital connects organizations, brands, technology and people through design-driven transformation, creating amazing customer experiences and building digital products. We are specialized in Digital transformation leveraging Salesforce. BayBridgeDigital operates in America, Europe and Middle East.

Guardion Health Sciences, Inc. (Nasdaq: GHSI), is a clinical nutrition and diagnostics company. Guardion offers a portfolio of science-based, clinically supported nutrition, medical foods, and supplements that support healthcare professionals, their patients, and consumers in achieving health goals. Guardion's commercial and developmental initiatives are supported by equally impressive scientific and medical advisory boards, led by seasoned business executives and physicians with many years of experience. By applying the latest science, technology and research, Guardion has positioned itself to address the escalating demand for solutions that promise to improve life-diminishing health problems. Guardion is dedicated to applying a scientific discipline and pharmaceutical approach to the development of safe, standardized and effective condition specific solutions. Using the individual and collective knowledge of the members of our Science Advisory Board, Guardion will advise healthcare professionals and the public on the importance of medical foods and nutrition to achieve overall good health.

A Global Alternative Investment Company

Strategic venture capital investment that translates great science into tomorrow’s healthcare.

Ansella Therapeutics is a specialty pharmaceutical company that focuses on the often overlooked details of well-understood biological systems and leverages novel materials science to create new treatment options for women’s health. Our patented, bio-inspired platform technology gives rise to a pipeline of over-the-counter (OTC) and prescription products that target improving vaginal health at all stages in life. Our flagship personal lubricant product is a first-in-class, biomimetic cream that unlocks the potential of cholesterol and fatty acids to maintain favorable cellular properties in the vaginal epithelium. Ultimately, this product is designed to mimic cervical and vaginal secretions and interface well with the dynamic vaginal mucosa.

BayBridgeDigital is a game changing new company that drives digital transformation to create new growth and business value faster. BayBridgeDigital connects organizations, brands, technology and people through design-driven transformation, creating amazing customer experiences and building digital products. We are specialized in Digital transformation leveraging Salesforce. BayBridgeDigital operates in America, Europe and Middle East.

Forepont Capital Partners is a Medtech and biotech focused venture capital firm which was founded in 2017, headquartered in New York with a presence in Europe. Our mission is to invest in biotech, medtech and digital-health start-ups in the US and Europe while providing scientific, technological financial and operational support. The fund has developed strong and tight partnerships with industry leaders (researchers, hospitals, academia, large pharmaceutical groups) who have vastly contributed to the performance of the existing portfolio, and that contributed to generating a proprietary deal flow.

Guardion Health Sciences, Inc. (Nasdaq: GHSI), is a clinical nutrition and diagnostics company. Guardion offers a portfolio of science-based, clinically supported nutrition, medical foods, and supplements that support healthcare professionals, their patients, and consumers in achieving health goals. Guardion's commercial and developmental initiatives are supported by equally impressive scientific and medical advisory boards, led by seasoned business executives and physicians with many years of experience. By applying the latest science, technology and research, Guardion has positioned itself to address the escalating demand for solutions that promise to improve life-diminishing health problems. Guardion is dedicated to applying a scientific discipline and pharmaceutical approach to the development of safe, standardized and effective condition specific solutions. Using the individual and collective knowledge of the members of our Science Advisory Board, Guardion will advise healthcare professionals and the public on the importance of medical foods and nutrition to achieve overall good health.